Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home

Search results

64 items matching your search terms.
Filter the results.
Item type

























New items since



Sort by relevance · date (newest first) · alphabetically
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes
Desmares et al., Antiviral Research, 2022 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
The broad viral inhibitors IFITMs can regulate Golgi trafficking
Li Zhong, Yuxin Song, Federico Marziali, Rustem Uzbekov, Xuan-Nhi Nguyen, Chloé Journo, Philippe Roingeard, Andrea Cimarelli
Located in Teams / Cimarelli A - LP2L / News
Association of IFNAR1 and IFNAR2 with COVID-19 severity
The Lancet Microbe: Yaugel-Novoa M., Bourlet T., Longet S., Botehlo-Nevers E, Paul S. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00095-2/fulltext
Located in Teams / Paul S - GIMAP / Actualités
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection
Vaccines: Yaugel-Novoa M., Noailly B., Jospin F., Berger A.E., Waeckel L., Botelho-Nevers E., Longet S., Bourlet T., Paul S. https://www.mdpi.com/2076-393X/11/4/773
Located in Teams / Paul S - GIMAP / Actualités
An inventory of adjuvants used for vaccination in horses: the past, the present and the future.
Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain PO.
Located in Teams / VIDALAIN PO - VIRIMI / News
Alteration of microbiota antibody-mediated immune selection contributes to dysbiosis in Inflammatory Bowel Diseases
Eva Michaud, Louis Waeckel, Rémi Gayet, Roman Goguyer-Deschaumes, Blandine Chanut, Fabienne Jospin, Katell Bathany, Magali Monnoye, Coraline Genet, Amelie Prier, Caroline Tokarski, Philippe Gérard, Xavier Roblin, Nicolas Rochereau, Stéphane Paul. Embo Molecular Medicine. https://www.embopress.org/doi/full/10.15252/emmm.202115386
Located in Teams / Paul S - GIMAP / Actualités
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice
Moreews M ; Mathieu AL, Pouxvielh K... Marçais A, Walzer T, Belot A
Located in Teams / Walzer T - LYACTS / Actualités
TNF-α response in macrophages depends on clinical Legionella pneumophila isolates genotypes.
Guillemot et al. 2022. Virulence. doi: 10.1080/21505594.2021.2022861
Located in Teams / Doublet P/Jarraud S - LegioPath / Actualités de l'équipe
NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway
Cui S, Xia T, Zhao J, Ren X, Wu T, Kameni M, Guo X, He L, Guo J, Duperray-Susini A, Levillayer F, Collard JM, Zhong J, Pan L, Tangy F, Vidalain PO, Zhou D, Jiu Y, Faure M, Wei Y. Nat Commun. 2023 Dec 19;14(1):8440. doi: 10.1038/s41467-023-44201-2. PMID: 38114531
Located in Teams / VIDALAIN PO - VIRIMI / News
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.
Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C. Hepatol Commun. 2023 Apr 14;7(5):e0078.
Located in Teams / VIDALAIN PO - VIRIMI / News